AiRWA Inc. 8-K Summary: 2026 Annual Meeting Results
Business Context and Reporting Period
This Form 8-K reports the results of AiRWA Inc.'s 2026 Annual Meeting of Stockholders held on April 17, 2026. The meeting was conducted virtually. As of the record date (February 23, 2026), there were 42,142,432 shares of common stock outstanding. A quorum was established with 19,689,058 shares represented.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and shareholder voting outcomes.
Material Changes and Voting Outcomes
Stockholders approved six proposals at the Annual Meeting:
- Proposal One (Election of Directors): All five nominees (Thomas Tarala, Hongyu Zhou, Chenlong Liu, Hai Bin Cui, Bini Zhu) were elected. Votes withheld ranged from approximately 475,000 to 637,000 per director.
- Proposal Two (Auditor Ratification): Enrome LLP was ratified as the independent registered public accounting firm for the fiscal year ending April 30, 2026. Votes For: 19,259,173; Votes Against: 182,653.
- Proposal Three (Share Incentive Plan Amendment): Approved an amendment to the 2026 AiRWA Share Incentive Plan to increase available shares to 3,500,000 and add an "evergreen" provision allowing an annual increase of up to 8% of outstanding shares through 2030. Votes For: 18,117,448; Votes Against: 1,497,747.
- Proposal Four (Reverse Stock Splits): Approved authority for one or more reverse stock splits over the next two years at a ratio between 1-for-40 and 1-for-800. The Board will determine the specific ratio and effective date. Votes For: 18,231,409; Votes Against: 1,448,915.
- Proposal Five (Say-on-Pay): Non-binding advisory vote on executive compensation was approved. Votes For: 18,684,202; Votes Against: 872,868.
- Proposal Six (Say-on-Pay Frequency): Stockholders voted to hold future advisory votes on executive compensation every 3 years. Votes For 3 Years: 18,056,979.
Guidance, Outlook, and Risks
The filing does not contain management commentary on financial guidance, outlook, or specific risks beyond the authorization of the reverse stock split, which implies a strategic move to adjust share price or meet listing requirements. The approval of the reverse stock split grants the Board significant discretion to execute the split within the approved range.
Investor Verification Checklist
- Verify the specific ratio and effective date for the reverse stock split once announced by the Board.
- Monitor the implementation of the "evergreen" provision in the 2026 Share Incentive Plan to assess potential future dilution.
- Review the definitive proxy statement filed on April 6, 2026, for detailed biographies of the newly elected directors.
- Check subsequent filings for the official execution of the reverse stock split and any resulting changes to share count.